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Enhanced Invasive Properties Exhibited by Smooth Muscle Cells are
Associated with Elevated Production of MMP-2 in Patients with
Aortic Aneurysms
S. Goodall, K. E. Porter, P. R. Bell and M. M. Thompson
Department of Surgery, University of Leicester, U.K.
Background: abdominal aortic aneurysms (AAA) are associated with excessive vascular matrix remodelling. Recent
findings suggest a systemic overproduction of matrix metalloproteinases-2 (MMP-2) by vascular smooth muscle cells
(SMC) may be pivotal aetiologically. SMC migration is facilitated by MMP mediated proteolysis of the basement
membrane and extracellular matrix. Our aim was to see if enhanced MMP-2 production by these SMC exhibit increased
invasion, in an in vitro model of migration.
Method: SMC were derived from inferior mesenteric vein (IMV) harvested from patients undergoing aneurysm repair
(n 6) or colectomy for diverticulosis (n 6, control). Using a modified Boyden chamber chemotaxis was measured
towards platelet derived growth factor (PDGF) and foetal calf serum (FCS) and invasion through a Matrigel layer.
MMP-2 production was quantified by ELISA and gelatin zymography.
Results: chemoattractant studies demonstrated no difference in the effect of PDGF or FCS between the two populations of
SMC. However, invasive studies demonstrated a significant increase in the number of migrating SMC isolated from IMV of
AAA patients. Analysis of culture media extracts revealed that this difference was associated with a significant increase in
production of MMP-2.
Conclusion: SMC derived from patients with AAA demonstrate increased invasive properties when compared to a control
group. Increased migration appears to be due to overproduction of MMP-2. The enhanced migratory potential of these SMC
may lead to extracellular matrix remodelling and subsequent medial disruption demonstrated in the aneurysmal aorta.
These data further support evidence of the proteolytic role of MMP-2 in cell migration.
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The aneurysmal aorta represents a site of massive
extracellular matrix remodelling. Disruption of the
tunica media layer, resulting in the reduction of the
numbers of vascular smooth muscle cells (SMC)1 and
loss of the important viscoelastic protein elastin2±4 are
key features. This loss of structural integrity has been
associated with elevated proteolysis, in particular
a large inflammatory response5 and the presence of
matrix degrading metalloproteinases (MMPs).6 These
alterations in medial composition compromise aortic
function, leading to eventual dilation augmented by
arterial blood pressure.
Previous work has focused on utilising end stage
degraded tissue to study the proteolytic response,Please address all correspondence to: M. M. Thompson, Consul-
tant Vascular and Endovascular Surgeon, Department of Surgery,
Clinical Sciences Building, Leicester Royal Infirmary, Leicester
LE2 7LX, U.K.
1078±5884/02/010072  09 $35.00/0 # 2002 Elsevier Science Ltd. Alhowever the use of such tissue assumes that initiating
factors remain present during the secondary degen-
erative process. Unfortunately this may not be the
case. Several MMPs, MMPÿ1, ÿ2, ÿ3, and ÿ9, have
been identified in abnormally high concentrations in
aneurysmal tissue.7±9 Immunohistochemical tissue
analyses have shown that the prominent source of
MMPÿ1, ÿ3, ÿ9 in aneurysmal tissue is from macro-
phage like cells.10,11 Therefore their increased level in
large aneurysms is likely to represent a secondary
ensuing inflammatory response, rather than a primary
event.
The principle metalloproteinase in small aneurysms
is MMPÿ2,12 suggesting that it may have an aetio-
logical role in aneurysm formation. This enzyme has
substrate specificity for elastin, in addition it also has
the ability to degrade fibrillar collagen.13 Interestingly
the primary source of MMP-2 in the aneurysmal aorta
is the same medial SMC that are responsible for elastin
production.14 Further evidence implicating the early
involvement of MMP-2 was established by culturingl rights reserved.
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significantly greater amounts of MMP-2 than cells
derived from age matched controls.15,16
Although aneurysm formation appears a focal event
considerable evidence exists demonstrating the sys-
temic nature of this degenerative disease.17±19 Ward20
demonstrated systemic arterial dilation, and Baxter4
showed matrix remodelling remote from the aneur-
ysm site. Previously results from experiments carried
out in our laboratory have demonstrated changes in
structural integrity are not solely confined to the arter-
ial tree but also apparent in the venous system. In
these experiments matrix remodelling throughout
the entire vasculature was associated with a systemic
enhanced expression of MMP-2 by vascular SMC.21
Migration of SMC into the intima has been demon-
strated to be an important early stage in lesion forma-
tion during atheroslerosis and restenosis after angio-
plasty.22,23 Migration requires chemotaxis towards
a stimulus and invasion through the arterial wall.
Invasion is facilitated by proteases released by the
SMC which breakdown the restraining basement
membrane and extracellular matrix. MMPs also
appear to play a key role in this process.24,25 It is
conceivable that increased production of MMP-2
may lead to enhanced migration of SMC, thus
increased disruption and weakening of the medial
layer integrity.
The purpose of the present study was to establish if
this phenomenon of systemic increased production of
MMP-2 would affect the migratory properties of
SMC derived from inferior mesenteric vein (IMV).
Vein was collected from two groups of patients,
those with a significant abdominal aortic aneurysm
(AAA) and a control with no AAA. A modified boy-
den chamber was used to measure migration, initially
towards a chemoattractant and then across a Matrigel
membrane. Matrigel basement membrane matrix is
a solubilized basement membrane composed of
laminin, collagen IV, heparen sulphate, proteoglycan,
entactin and nidogen.26 This emulates the naturally
occurring basement membrane matrix.
Methods
Study design
This study was performed with the approval of
Leicestershire Research Ethics Committee. Two
groups of patients were recruited: six patients having
transperitoneal AAA repair, and six undergoing left
colonic resection for benign colonic pathology. Nodifference with regard to age; median AAA 73
(range 65±79), Vsi Control 69, (59±78) (Mann±
Whitney, p 0.394) or sex (Fisher exact test p 0.547)
was noted. Aortic diameter was significantly greater
in the AAA group (median 6.0 cm) compared to the
control group (52.5 cm) (Mann±Whitney p 0.002).
Tissue collection
At operation, a segment of inferior meseuteric veiu
was excised from a standard location immediately
anterior to the abdominal aorta. This was part of the
standard surgical procedure in both groups of
patients. This vein was immediately placed in min-
imal essential medium on ice and transported to the
laboratory.
Cell culture
Vascular smooth muscle cells were obtained from a
1cm length of vein. The vein was immediately freed of
blood and adipose tissue by washing with cold MEM.
This tissue was then minced into 1 mm3 pieces
and suspended in 12 ml of sterile smooth muscle
cell medium (RPMI 1640 containing 50 000 IU/L
penicillin/streptomycin and 2 mM L-glutamine) (all
Gibco BRL, Grand Island, NY, U.S.A.) and 10% foetal
bovine serum (Imperial Lab., U.K.). These explants
were dispersed between four 25 cm2 tissue culture
flasks (Nunclon, Gibco, Paisley, U.K.) and placed in
a 95% air/5% CO2 humidified incubator at 37
C.
Cultures were passaged once cellular outgrowths
from the explants had reached 80% confluence (20±
30 days), this was achieved by light Trypsinasation
(0.1% trypsin, 0.02% EDTA 0.02 M Hepes (Gibco,
Pailsey, U.K.) in phosphate buffer saline) and replat-
ing in two 75 cm2 sterile tissue culture flasks
(nunclon). All cultures were maintained by regular
partial replenishment of culture medium. Once the
third passage was achieved SMC were ready to use.
Immunohistochemical staining for a-smooth muscle
actin positively identified isolated SMC (Fig. 1).
No cells were positively identified with fibroblast
vimentin.
Proliferation rate
Trypsinised cells were plated into six well plates
(nunclon) in culture media containing 10% foetal
bovine serum at a density of 5 104 cells per well.
They were allowed to adhere overnight, and were
incubated at 37 C in a 95% air/5% CO2 humidified
chamber for 12 days. At days 2, 4, 6, 8, 10 and 12 SMCEur J Vasc Endovasc Surg Vol 24, July 2002
Fig. 1. Proliferation curves, demonstrating no difference in prolifer-
ation rates between the two SMC populations.
74 S. Goodall et al.from one well were released from the surface using
trypsin and counted using a haemacytometer. A
growth curve was plotted using data from all cell
lines and the area under the curve used to compare
the two groups of patients.
Chemoattractant experiment
Once cells had reached 80% confluence, they where
made quiescent for 72 h using 0.4% FSC in (RPMI 1640
containing 50 000 IU/L penicillin/streptomycin and
2 mM L-glutamine). They were released from the
flask by light trypsinisation, centrifuged and resus-
pended in 1 ml of 0.25% BSA in Dulbeccos modified
eagle medium (DMEM) (Gibco BRL, Grand Island,
NY, U.S.A.) so they could be counted. Migration was
measured using a modified 24 well Boyden chamber
with cell culture inserts containing 8 mM pores (Becton
Dickinson, Cowley, U.K.). To the lower chamber was
added either 750 ml migration medium, 750 ml migra-
tion medium containing 10 mg/ml PDGF or 750 ml of
10% FCS in DMEM. To the upper chamber was added
0.75 105 SMC in 500 ml of migration medium. Migra-
tion was allowed to proceed at 37 C in a 95% air/5%
CO2 humidified incubator for 6 h. The cell culture
insert was fixed in 70% ethanol at ÿ20 C for 1 h and
then the lower part of the membrane was stained
using haematoxylin and eosin before mounting on
slides. Migratory SMC were counted at 40 magni-
fication, only cells with complete nuclei were counted
and an average taken from ten fields of view used.
Migration through Matrigel inserts
Cell culture inserts were coated with Matrigel (Becton
Dickinson) prior to use. The Matrigel was thawedEur J Vasc Endovasc Surg Vol 24, July 2002slowly on ice overnight, then diluted in PBS. 100 ml
of this solution was added to each insert to give a
final covering of Matrigel of 65 mg/cm2. Inserts were
placed at 28 C overnight to allow polymerisation
of the Matrigel coating. Before use, the inserts were
rehydrated in 250 ml of migration medium.
Invasion through Matrigel coated inserts was car-
ried out using the same procedure as uncoated plate
as previously described, with the exception that
1.5 105 cells were initially placed in the top chamber
and migration was allowed to occur for 48 h.
Gelatin zymography
Substrate gels were prepared by incorporating gelatin
(1 mg/ml) (Sigma, Poole, U.K.) into a 10% SDS-
polyacrylamide gel. 15 ml of cell culture media, plus
an equal volume of 2 non reducing sample buffer
(46% Glycerol, 4.1% SDS and tris HCl 64 mM pH 6.8
plus 2 drops of bromophenol blue) were loaded onto
the gel. Molecular weight standards (Novex, San
Diego, U.S.A.) and a positive control (cultured media
from HT1080 human fibrosarcoma cells ECACC
No 85111505) were also added. Electrophoresis was
performed using a Mini- protein II system (BioRad,
Hemel Hempstead, U.K.) at 60 mA for 4 h at 4 C.
After this the gels were washed three times in 2.5%
Triton X-100 (Sigma, Poole, U.K.) and incubated at
37 C in buffer (Tris HCl 50 mM pH 7.6, CaCl 10 mM,
0.05% Brij) for 18 h Lysis bands were visualized using
0.1% coomassie blue R250 dissolved in a solution of
50% Methanol, 20% acetic acid. The amount of
lysis was compared by analysis using densitometic
methodology.
Data analysis
Cell proliferation data was extrapolated using
Seraplot software to find the area under the
curve. All other statistical tests, Mann±Whitney and
Wilcoxon analyses were carried out using Prism
GraphPad software. A Probability value of 55%
(p 0.05) was considered statistically significant.
Results
Proliferation rates
To avoid the possibility that any differences in
cell migration were due to increased proliferation;
cell proliferation rates were measured. An initial
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alternate days, for 12 days, under normal conditions.
After an initial period of 1 day which allowed for the
cells to adhere, the proliferation rate was linear until
approximately day 10 when confluence was
approached. Proliferation curves were plotted and
the area under the curve was calculated for each cell
line, so the two groups could be compared (Fig. 1).
There was no significant difference in the proliferation
rates between the two groups of cell lines, as deter-
mined by Mann±Whitney (U 12, p 0.3939). AAA
group n 6, median area 1.417 106, and control
group n 6, median area 1.575 106. Therefore
it can be assumed that any difference in migratory
properties were not due to any imbalance in SMC
proliferation.Fig. 2. Shows SMC chemotaxis through the uncoated inserts towards
(a and d). A, b and c are SMC derived from patients with AAA, whilsMigration towards chemoattractants
SMC migrate towards specific chemoattractants. In
these experiments, PDGF or FCS was used to assess
any difference in general chemoattraction properties
between the two cell populations (Fig. 2). Using no
chemoattractant, after 6 h of migration through the
membrane the median count on the lower chamber
had reached 0.4 cells in the AAA group and 0.7 cells in
the control group. This represented no significant dif-
ference determined by Mann±Whitney (U 14.5,
p 0.5887). Using PDGF as chemoattractant, after 6 h
of migration through the membrane the lower cham-
ber had reached a median count of 2.5 cells in the
AAA group and 3.7 cells in the control group. This
represented no significant different in migrationPDGF (b and e), FCS (c and f) and also towards no chemoattractant
t d, e and f are SMC derived from control patients (80).
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Table 1. Represents the median number of cells, counted in a 100
microscope field, that had migrated towards PDGF or FCS, either
though a porous membrane (chemotaxis) or though a Matrigel
coating membrane (invasion). No difference in chemotaxis was
observed, but invasive properties were dramatically enhanced in





Chemotaxis Control 0.4 (0.2±1.75) 0.7 (0.3±1.5) 0.589
PDGF 2.5 (1.4±6.2) 3.7 (2.4±11.9) 0.394
FCS 2.8 (1.6±5.2) 2.6 (2.0±5.2) 0.937
Invasion Control 1.2 (0.7±2.8) 0.5 (0.3±0.8) 0.240
PDGF 49.2 (42.2±56.9) 22.4 (20.5±24.5) 0.004
FCS 29.3 (28.2±30.2) 14.6 (10.8±16.3) 0.004
76 S. Goodall et al.towards PDGF determined by Mann±Whitney
(U 12, p 0.3939). Using FCS as chemoattractant,
after 6 h of migration through the membrane the
lower chamber had reached a median count of 2.75
cells in the AAA group and 2.55 cells in the control
group. This represented no significant difference in
the migration towards FCS determined by Mann±
Whitney (U 17.5, p 0.937). There is clearly no dif-
ference in the chemoattraction properties exhibited
by either SMC populations toward PDGF or FCS
(Table 1).
Migration through a Matrigel membrane
The Matrigel membrane is designed to mimic the
basement membrane surrounding cells. In order to
pass through the matrigel coated inserts the SMC
must first create a path through the laminin and
collagen fibres. The only way this can be achieved is
by direct proteolysis of the fibres by degrading
enzymes released from the SMC. Therefore, this
represents a realistic mode of migration as seen in
vivo. Figure 3 shows representive stained slides of
SMC after migration.
Using no chemoattractant, after 48 h of migration
through the Matrigel membrane the median count
on the lower chamber had reached 1.15 cells in the
AAA group and 0.45 cells in the control group. This
represented no significant difference determined by
Mann±Whitney (U 10.5, p 0.2403). Using PDGF
as chemoattractant, after 48 h of migration through
the Matrigel membrane the median count on the
lower chamber had reached 49.15 cells in the AAA
group and 22.35 cells in the control group. This
represented a highly significant increase in migration
exhibited by the AAA derived SMC, determined byEur J Vasc Endovasc Surg Vol 24, July 2002Mann±Whitney (U 1.0, p 0.0043). This significant
increase demonstrated by the SMC derived from
patients with AAA was also observed using FCS as
chemoattractant. After 48 h of migration through
the Matrigel membrane the median count on the
lower chamber had reached 29.3 cells in the AAA
group and 14.63 cells in the control group. (Mann±
Whitney U 1.0, p 0.0043). These data clearly
demonstrate that SMC derived from patients with
AAA have the ability to migrate more efficiently
through a Matrigel membrane than the control group
(Table 1).
Zymography
The migration results demonstrate that there is no
difference in migration towards chemoattractants.
However once a Matrigel membrane is placed
between these migrating cells and the stimuli, the
cells derived from patients with AAA migrate in lar-
ger numbers. This difference must represent a differ-
ence in the proteolytic capacity of the two groups
of SMC.
To assess gelatinolytic activity, media was taken off
the upper chamber after migration had occurred and
subjected to gelatin zymography. Figure 4 demon-
strates a typical zymogram, showing increased levels
of MMP-2 and ProMMP-2 in the AAA group, and no
difference in the levels of MMP-9. Scanning densito-
metry of these zymograms demonstrated levels of
proMMP-2 to be significantly higher in the AAA
group. This was true for no chemoattractants, median
optical density was 1.206 for the AAA group
and 0.8196 for the control group (Wilcoxon W 21,
p 0.0313); PDGF median optical density was 1.271
for the AAA group and 0.8550 for the control group
(Wilcoxon W, 21, p 0.0313, and FCS median optical
density was 1.098 for the AAA group and 0.7680 for
the control group (Wilcoxon W 21, p 0.0313).
ELISA data also demonstrated levels of MMP-2 to
be significantly higher in the AAA group (Table 2).
This was true for no chemoattractants, median
39.6 ng/ml for the AAA group and 18.15 ng/ml
for the control group (Mann±Whitney U 2,
p 0.0087). PDGF, median 36.2 ng/ml for the AAA
group and 25.1 for the control group (Mann±Whitney
U 1, p 0.0043) and FCS median was 33.8 ng/ml
for the AAA group and 16.9 ng/ml for the con-
trol (Mann±Whitney U 0, p 0.0022). These data
demonstrated that there is a correlation between
increased invasion of SMC and elevated production
of MMP-2.
Fig. 3. Shows SMC invasion through Matrigel coated inserts towards PDGF (b and e), FCS (c and f) and also towards no chemoattractant
(a and d). A, b and c and SMC derived from patients with AAA, whilst d, e and f are SMC derived from control patients. These results
demonstrated the enhanced invasive properties exhibited by the SMC derived from patients with AAA (160).
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The most abundant cell population in arteries is
SMC, which comprise most of the medial layer.
Under normal physiological conditions they are res-
ponsible for maintaining homeostasis and providing
mechanical strength. They achieve this by supplying
vessel wall rigidity, elasticity and governing blood
pressure. In this contractile state the SMC demonstrate
limited metabolic activity and absence of cell division.
This tight control is lost during injury to the vessel
wall, leading to a profound alteration in phenotype
resulting in proliferation and an ability to migrate
from the medial layer.27 This switch in phenotype isthought to occur by several methods: stretch and pres-
sure forces acting on the wall,28 extracellular matrix
remodelling around the anchored SMC,29 interactions
with growth factors30 and interactions with platelets
and leukocytes.28
Activated SMC rely on chemotaxis towards a che-
moattractant for direction of movement. An example
of this is the release of PDGF by platelets that have
attached to damaged intima after injury.31 PDGF is
a potent chemoattractant and the high concentration
on the intima side of the vessel creates a gradient for
SMC to travel towards. However, if SMC are able to
migrate toward these chemoattractants they must be
detached from their adhesion molecules and createEur J Vasc Endovasc Surg Vol 24, July 2002
Fig. 4. (A) Representive gelatin zymogram of migration media taken
during invasion through Matrigel coated inserts. MMP-2 can be seen
as a lytic band at 72 kDa, active MMP-2 can be seen as a lytic band at
66 kDa and MMP-9 can be seen as a lytic band at 92 kDa. This
demonstrated the increased amount of MMP-2 being produced
from the SMC derived from the AAA patients. Human fibrosarcoma
HT1080 cell media was used as a standard. (B) ELISA data showing
a significant increase in the amounts of MMP-2 produced by SMC
derived from patients with AAA.
Table 2. ELISA data showing a significant increase in the amounts
of MMP-2 within the migration medium produced by SMC
derived from patients with AAA (median and interquartile
ranges).
MMP-2 concentration ng/ml p value
AAA Control
Control 39.6 (35.9±43.3) 18.2 (16.3±21.0) 0.009
PDGF 36.2 (30.7±42.1) 25.1 (20.2±28.7) 0.004
FCS 33.8 (33.4±34.7) 16.9 (15.9±20.2) 0.002
78 S. Goodall et al.a path through the basement and extracellular mem-
branes. This is achieved by proteinases released by the
SMC. Two classes of proteinases are thought to be
responsible for this, the urokinase-type plasminogen
activator (uPA) and the matrix metalloproteinases
(MMP).32 Recent findings have identified the involve-
ment of the uPA system,33 but it remains unclear
whether it has direct influence or if plasmin simply
acts as an MMP activator.Eur J Vasc Endovasc Surg Vol 24, July 2002The involvement of the MMP family of enzymes
during migration has been demonstrated by inhibitor
studies. TIMP (tissue inhibitor of MMP) over
expression24,34 and synthetic inhibitors25 have been
used successfully to prevent SMC migration in vitro.
Various members of the MMP family have been impli-
cated in SMC migration, however the strongest has
focused on MT1-MMP activation of MMP-2.35 MMP-2
is attractive because it has basement membrane
degrading potential, it has substrate specificity for
collagen IV, elastin, laminin and fibronectin. Also,
SMC constitutively produce this powerfully degrad-
ing enzyme.36 Like most MMPs, MMP-2 is released
by the SMC as an inactive zymogen. Activation is
mediated by the formation of a trimeric complex
with MT1-MMP and TIMP-2 at the cell surface. There-
fore activated MMP-2 and MT1-MMP form a local-
ised collagenolytic region on the cell surface, ideal
for breaking down components of the basement
membrane.
The Boyden chamber model is a useful tool for
accurate measurements of SMC migration. This sys-
tem allows the user to regulate the SMC environment
and alter individual components involved in migra-
tion in a way that is impossible in vivo. The SMC were
placed in the upper chamber and migration across the
microporous membrane was quantified by micro-
scopy. By incorporating a Matrigel coating to the
membrane, invasion through the basement membrane
was also observed. Using this technique SMC derived
from patients with AAA consistently migrated
through the Matrigel coating in greater numbers
than the SMC derived from the control group. Prolif-
eration and chemotaxic studies demonstrated this
enhanced invasive quality was not due to increased
proliferation or greater chemotaxis properties. There-
fore any difference in invasion must represent an
alteration in the proteolytic component expressed
by SMC.
Previous work by Crowther15 demonstrated that the
production of MMPs, including MT1-MMP and
TIMP-2, by isolated SMC derived from patients with
AAA and controls were identical, however MMP-2
was upregulated in the AAA group. The overproduc-
tion of MMP-2 by SMC derived from patients with
AAA appears to be systemic affecting all SMC
throughout the vascular tree.21 In this previous study
levels of mRNA, extracted from SMC derived from
patients with aneurysmal disease, were significantly
higher than that of a non-aneurysmal matched con-
trol. Currently work is ongoing in our institute to
establish whether this phenomenon is related to poly-
morphisms of the promoter region of the MMP-2 gene
or simply mRNA stability.
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from AAA patients would consistently produce larger
quantities of matrix degrading MMP-2 than the con-
trol during this model of migration. This was demon-
strated by analysing migration media extracted from
the migrating SMC. Both pro and active forms of
MMP-2 were present in significantly higher levels
than in the control cells. Therefore it would appear
that this association of enhanced MMP-2 production
and increased SMC invasion is critical. Interestingly
no difference in the levels of MMP-9 was demon-
strated. This result may appear to contradict those
of other investigators who demonstrated elevated
levels of MMP-9 in tissue sections from mature
aneurysms.7±9 However these studies demonstrated
the major source of this enzyme and indeed other
MMPs within the tissue extracts were infiltrating
inflammatory cells rather than SMC.
The migration of SMC from the media across the
internal elastic lamina into the subintima has been
noted to be an early stage in the formation of
lesions during atherosclerosis and restenosis after
angioplasty.22,23 Indeed, SMC migration may explain
the presence of atherosclerotic lesions found in
developed aneurysmal tissue. Elastases degrade the
extracellular matrix, releasing growth factors and
chemotactic peptides37 resulting in dramatic vascular
remodelling and a stretched vessel wall. Induction of
glycoproteins such as tenascin is also increased by this
elastase activity,38 which can enhance cell proliferation
and migration. Therefore the aneurysmal aorta repre-
sents a migratory friendly environment for SMC.
Combined with the overexpression of MMP-2 it is
conceivable that matrix disruption may be increased
by this enhanced migration.
One potential drawback of this study was the choice
of control tissue. IMV was biopsed from patients
undergoing left colonic resection for benign colonic
pathology. This group of patients was chosen because
they were an available source of tissue that was absent
of aneurysmal disease. Additionally, no differences in
age or gender were noted between these two groups.
Although putative evidence suggests that aneurysmal
and atherosclerotic disease are two distinct entities, it
is clear that repeating these experiments using control
tissue obtained from patients with atherosclerosis is
warranted.
In conclusion, SMC derived from patients with
AAA demonstrate enhanced invasive properties
when compared to a control group. This increased
invasiveness appears to be associated with elevated
production of matrix degrading MMP-2. MMP-2 is
thought to be pivotal to the aetiology of this degen-
erative disease, and it's enhanced production duringthe ensuing inflammatory infiltrate may certainly
potentiate further damage to the extracellular matrix
with the presence of migratory stimulants. These find-
ings might suggest that medial disruption and
increased extracellular matrix remodelling are key
features of AAA. These data further support the
importance of MMP-2 during smooth muscle cell
migration. Understanding the factors that modulate
matrix catabolism may lead to the development of
novel pharmacological agents, which can specifically
inhibit those enzymes that demonstrate a contributory
affect. This could potentially lead to a cessation in the
growth of small aneurysms.
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